Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 42708-150

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 42708-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (3a53f18e Af9b 4932 8300 B3521e87528d 01)

Chemical structure diagram of Lisinopril, one of the active ingredients in Lisinopril and Hydrochlorothiazide tablets by QPharma, Inc. The diagram shows molecular bonds and groups, including a dihydrate form indicated by .2H2O.*

FDA Label Image

Figure 2 (3a53f18e Af9b 4932 8300 B3521e87528d 02)

Chemical structure diagram of the active pharmaceutical ingredient associated with Lisinopril and Hydrochlorothiazide tablets. The diagram shows a heterocyclic aromatic compound with chlorine and sulfonamide functional groups.*

FDA Label Image

Label (42708 150 30)

Label for Lisinopril and Hydrochlorothiazide Tablet USP, 10 mg/12.5 mg, supplied in a 30-tablet package. The label is from QPharma, Inc. and includes instructions for dosage and storage at controlled room temperature. It is marked as a sample, not for sale, with spaces to fill in specific dosing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.